BioSpace News Archive

Bio-Techne Corporation announced that Jim Hippel, Chief Financial Officer will present at the Barclays Global Healthcare Conference on Wednesday, March 13th, 2019, at 9:00 a.m. EST.

Enables Operational Efficiencies and Supports Full U.S. DSCSA and EU FMD Compliance Requirements for Companies with Warehousing Operations

DolCas Biotech agrees to license several well-known trademarks, including BCM-95®, to Arjuna Naturals

Senseonics Holdings, Inc. announced the integration of Eversense CGM data into the Glooko diabetes data management platform.

Propanc Biopharma, Inc. (OTCQB:PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that its Chief Executive Officer, James Nathanielsz, has been invited to present at the 31st Annual ROTH Conference being held on March 17 – 19, 2019

Event to examine knowledge gaps and opportunities for robust scientific research into cannabinoid applications and their role in the evolving landscape

Survey Results Offer an Inside Look at Deal Dynamics across a Wide Range of High Tech Sectors from Aerospace, Computing, Communications to Electronics, Medical, and Beyond

Victoria Smith, Ph.D. Named Chief Scientific Officer; Peter Van Vlasselaer, Ph.D. Appointed Executive Chairman of the Board

This funding will help Tasso scale its first product Tasso OnDemand, which enables self-collection of blood samples, and grow the team to support significant commercial interest.

The purpose of Part 3 is to explore safety, and additional indications in rare and gastrointestinal tumors.